Compare Bio Protocol (BIO) vs Polkadot (DOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Polkadot — how do they compare? Bio Protocol trades at Rp512.66 (market cap Rp1,16T, Rp252,63M 24h volume), while Polkadot trades at Rp15,000 (market cap Rp25,41T, Rp1,29T 24h volume). The key difference: Polkadot is far larger — about 21.9× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 1,7B / 2,1B DOT (81%) for Polkadot. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Polkadot for 116 Days on average.
| BIO | DOT | |
|---|---|---|
Market Cap | Rp1,16T | Rp25,41T |
Volume (24h) | Rp252,63M | Rp1,29T |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 1,7B / 2,1B DOT (81%) |
Typical Hold Time | 16 Days | 116 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Polkadot is currently trading at Rp15,047 with a bearish technical outlook, showing selling pressure across moving averages while oscillators remain neutral. The asset holds a market cap of Rp25.48T with 81% of max supply in circulation. Current price sits near support at Rp15,057 with resistance at Rp15,429. No major protocol updates or ecosystem developments were reported recently.
Overall outlook remains cautious with technical indicators favoring sellers. Key opportunities include potential bounce from support levels, while risks include continued bearish momentum and lack of recent fundamental catalysts. Investors should monitor network activity and trading volume patterns for directional cues.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Polkadot
A crypto asset founded by Gavin Wood (a co-founder of Ethereum) alongside co-founders Peter Czaban and Robert Habermeier in 2016. It was finally launched in 2020 with the goal of incentivizing the global network of computers to use blockchain for its operation which users can launch and operate their own blockchains system.
Read more on DOT →
